Resources by service
Strategies For The Future of Temperature Controlled Logistics
Almac Clinical Services and Pharma Logistics IQ proudly present the findings of their 2016 Temperature Controlled Logistics Future Trend Report, which examines the oncoming strategies likely to blossom in the cold chain industry.
The future of the pharma cold chain logistics industry is in good shape, with sturdy growth being forecast for the $12 billion market. Many experts are of the opinion that a range of trends are due to take hold in the industry in the near future. The rise of cell and gene therapies and the logistics paths they require (patient to manufacturer to patient, for instance) and the inherent sensitivity of the biomaterials will place new demands on the industry.
You will hear from our industry leader Heather Bogle, Supply Chain Solutions Manager at Almac Clinical Services, as she discusses the temperature services industry as a key priority. Within this report it outlines where stakeholders in the international cold chain community stand on issues such as:
- How important is it to strive towards being future proof as a temperature controlled logistics organisation?
- What area will be the most damaging to your firm if you don’t adapt and innovate quickly?
- What are investment plans over the next 12 months for optimising temperature controlled logistics?
*By submitting your information you acknowledge that you have read the privacy statement and you consent to our processing the data in accordance with that privacy statement. We may, from time to time, send you material relevant to your interests. If you change your mind at any time about wishing to receive material from us, you can send an email to email@example.com. Every email we send you will also include an unsubscribe link so you can unsubscribe from our marketing list.